Perth-headquartered bio-nanotech company pSivida Ltd will raise around $21.3 million through the sale of its American Depository Shares and warrants to pharmaceutical giant Pfizer Inc, under the $203 million research deal announced earlier this year. The company estimates that net proceeds from the offering will be around $19.4 million after deducting placement agent fees and estimated offering expenses.
